Clinical trial · Interventional
Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway
NCT03240341CI-TRIAL-00066206PARACTcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim is to implement the Patient Activation Measure in paramedical practices as a tool to measure activation of patients in cancer care
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient Activation Measure Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patient Activation Measure (PAM)
- description
- completion of the PAM questionnaire
- interventionNames
- Behavioral: Patient Activation Measure Questionnaire
Primary outcomes (1)
- measure
- Patient Activation Measure Questionnaire
- timeFrame
- 12 month
Secondary outcomes (5)
- measure
- Patient Activation Measure Questionnaire
- timeFrame
- 6 and 12 months
- measure
- Visual Analog Scale for confidence level measurement about treatment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age over 18 years * Cancer patient with an estimated life expectancy of at least one year * Patient requiring immunotherapy or intravenous chemotherapy for any cancer according to the decision of the Multidisciplinary Consultation Meeting * Patient affiliated or entitled to a social security scheme Exclusion Criteria: * Refusal to participate, protected adult patient under guardianship. * Patient disability to understand the course of the study * Patient with documented history of cognitive or psychiatric disorders. * Patient not understanding French
References
Publications (1)
- DERIVEDVerot E, Bouleftour W, Macron C, Rivoirard R, Chauvin F. Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version. JMIR Res Protoc. 2020 Dec 8;9(12):e17485. doi: 10.2196/17485. PMID 33289495